Surrozen, Inc. closed the second tranche of its March 2025 private placement, raising approximately $95.1 million. This funding strengthens the company's balance sheet and provides cash runway through 2029 to advance clinical trials for its ophthalmic drug candidates SZN-8141 and SZN-8143, targeting diabetic macular edema and other retinal diseases. The proceeds will support the DUET Phase 1b/2a study for SZN-8141 and initial clinical development of SZN-8143, with patient dosing expected to start in late 2026 and initial data anticipated in 2027. This financial milestone positions Surrozen to continue innovating in treatments for sight-threatening eye conditions.
Surrozen's recent $95.1 million private placement closing provides important financial backing as of October 21, 2026. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 21, 2026 03:11 WIB: out of 150 priced US health stocks, 124 rose and 26 fell today. Notable movers include Moderna (MRNA) at USD 242.45 with a 1-day change of +6.86% and a typical hold time on Pluang of 59 days, Definium Therapeutics (DFTX) at USD 35.19 up 6.73%, and Nuvation Bio (NUVB) at USD 4.78 up 6.70%.
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Collector Crypt, a Solana-based marketplace that tokenizes physical trading cards, has surpassed both Hyperliquid and Papertrade in 24-hour revenue, reaching over $532,550. This signals a shift in the crypto market towards tokenized collectibles rath...
